Bill Text - SB289 (2022)

(New Title) relative to glucagon administration and relative to the dispenser report under the controlled drug prescription health and safety program.


Revision: April 1, 2022, 10:41 a.m.

Rep. Merchant, Sull. 4

March 24, 2022

2022-1223h

10/

 

 

Amendment to SB 289

 

Amend the title of the bill by replacing it with the following:

 

AN ACT relative to glucagon administration and relative to the dispenser report under the controlled drug prescription health and safety program.

 

Amend the bill by replacing all after section 1 with the following:

 

2 New Subparagraph; Controlled Drug Prescription Health and Safety Program; Dispenser Report. Amend RSA 126-A:91, VI by inserting after subparagraph (o) the following new subparagraph:

(p) The format of the prescription: electronic, faxed, written, oral, or other.

3  Effective Date.  

I. Section 1 of this act shall take effect 60 days after its passage.

II. The remainder of this act shall take effect upon its passage.

2022-1223h

AMENDED ANALYSIS

This bill changes a statutory reference from glucagon injections to glucagon administration.  This bill also adds a requirement to the dispenser report under the controlled drug prescription health and safety program.